The levels of myocardial fibrosis markers (MMP-3, collagen, tumor growth factor (TGF-β), vascular endothelial growth factor (VEGFA), and procollagen I C-terminal propeptide (PICP)) were assessed in patients of both groups. This evidence concerns the gene TGFB1 and Myocardial fibrosis.